Inductive Bio Launches Indy AI Assistant for Drug Discovery
Boston, Massachusetts, September 15, 2026 Inductive Bio has launched Indy, an artificial intelligence-powered chemistry assistant designed to help medicinal...
Abbott
Advertisement
Abbott Resolves 2022 Infant Formula Claims Through DOJ Deal
Abbott Park, Illinois, September 14, 2026 Abbott has reached an agreement with the U.S. Department of Justice (DOJ) and...
Abbott Gains FDA Authorization for Dual Glucose-Ketone Sensor
ABBOTT PARK, Ill., August 25, 2026 Abbott announced that the U.S. Food and Drug Administration (FDA) has authorized Libre...
Abbott and NACHC Expand Nationwide Food for Health Initiative
Abbott Park, Illinois and Bethesda, Maryland, August 17, 2026 Abbott and the National Association of Community Health Centers (NACHC)...
ALZpath Expands Global Leadership in Alzheimer’s Blood Biomarkers
CARLSBAD, California, July 13, 2026 ALZpath, Inc. has announced a major scientific milestone at the Alzheimer’s Association International Conference...
Advertisements
Freenome Reports Strong SimpleScreen CRC Study Results
BRISBANE, Calif. | July 9, 2026 Freenome, an early cancer detection company advancing blood-based cancer screening technologies, has announced...
Abbott Strengthens Leadership in CRC Screening
ABBOTT PARK, Ill., May 27, 2026 Abbott has announced that the updated American Cancer Society (ACS) colorectal cancer screening...
Abbott Ultreon 3.0 AI Imaging Gains FDA, CE Approval
ABBOTT PARK, Illinois, USA, April 28, 2026 Abbott has announced that its next-generation Ultreon™ 3.0 AI-powered coronary imaging platform...
Abbott Showcases AFib Tech Breakthrough at HRS 2026
Abbott Park, Illinois | April 25, 2026 Abbott has unveiled late-breaking clinical data at the Heart Rhythm Society (HRS)...
Abbott Cancerguard Advances Multi-Cancer Detection Data
ABBOTT PARK, Ill., April 17, 2026 Abbott has unveiled new data at the AACR Annual Meeting 2026 demonstrating significant...
Advertisement
